logo
logo
Sign in

Genital Warts (Condyloma Acuminatum) Market Analysis and Opportunity Assessment 2023 to 2033

avatar
Ganesh Shinde
Genital Warts (Condyloma Acuminatum) Market Analysis and Opportunity Assessment 2023 to 2033

The global market for genital warts (condyloma acuminatum) is expected to be worth $1.87 billion in 2023, rising to $3 billion by 2033 at a CAGR of 4.84%. As new drugs are introduced, the dynamics of the genital warts market are expected to change in the coming years. Tamir Biotechnology (Orgenesis), Verrica Pharmaceuticals, Novan Inc., and others are developing drugs to treat genital warts. Furthermore, successful and well-communicated vaccination campaigns have raised public awareness of vaccines and their benefits, resulting in increased vaccine uptake. Furthermore, increased vaccination coverage has been linked to a decrease in genital wart occurrence.

Paladin Labs Inc., a subsidiary of Endo International plc., a pharmaceutical company, announced the July 2014 launch of Veregen (sinecatechins) Ointment, 10%, a topical treatment for external genital and perianal warts (condylomata acuminata) in immunocompetent patients aged 18 and older. Furthermore, continuous innovation in the healthcare sector increased consumer awareness and medical infrastructure investments. Several opportunities are likely to emerge in emerging and less developed countries during the forecast period, influencing market growth.

However, a lack of public awareness and understanding about vaccine accessibility and use, as well as growing concerns about the long-term side effects of therapies and expensive treatment alternatives, are expected to be significant impediments. There is a significant unmet need for targeted drugs with improved clinical profiles, lower costs, and a more convenient administration schedule. However, rising R&D spending on oncologic diseases promises a bright future for the market in the near future.

Competitive Landscape

Key players in the Genital Warts market are: Verrica Pharmaceuticals, Tamir Biotechnology, Novan Inc., Medicis Pharmaceuticals, Aresus Pharma, AbbVie, Sanofi S.A., AbbVie Inc, Perrigo Company PLC, Glenmark Pharmaceuticals. Some key developments in this market are:

Get More Insights@ https://www.futuremarketinsights.com/reports/genital-warts-condyloma-acuminatum-market

Key Segments Profiled in the Genital Warts Market Industry survey

Genital Warts Market by Treatment:

  • Chemical Treatment
  • Ablative Treatment
  • Preventive Treatment
  • Other Treatments

Genital Warts Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail pharmacies
  • Online Pharmacies


collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more